2cureX AB (publ) operates as a medical technology company in Europe. ts proprietary IndiTreat test family creates various three-dimensional tumoroids derived from fresh samples of colorectal cancer (CRC) tissue that has been obtained from an individual patient's metastatic colorectal cancer. 2cureX AB (publ) was incorporated in 2006 and is based in Landskrona, Sweden.
Frequently asked questions
What sector does 2cureX AB (2CUREX) operate in?
2cureX AB belongs to the Healthcare sector and operates in the Biotechnology industry.
What is 2cureX AB (2CUREX) current stock price?
As of the latest data, 2cureX AB stock price is SEK 1.58, with a previous close of SEK 1.61. 2cureX AB lost -SEK 0.03 in the last trading session, representing a -1.98% loss.
What is 2cureX AB (2CUREX) current market capitalization?
2cureX AB market cap is approximately 39.71 million.
What is 2cureX AB (2CUREX) Earnings Per Share (EPS)?
The trailing EPS is -SEK 0.42.
Does 2cureX AB (2CUREX) pay dividends?
No. 2cureX AB does not pay a dividend.
What is 2cureX AB (2CUREX) beta (volatility) score?
2cureX AB has a beta of 3.014, indicating very high volatility compared to the market.